Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.347, 2002-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
By McCrone Paul
PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. :
Natalizumab: multiple benefits in multiple sclerosis
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
Role of Cannabinoids in Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. :
Management of Children with Multiple Sclerosis
By Yeh E. Ann
Pediatric Drugs, Vol. 14, Iss. 3, 2012-06 ,pp. :